Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease

Otto, Jr. Mayer; Jitka Seidlerova; Jan Bruthans; Jan Filipovsky; Katarina Timoracka; Jiri Vanek; Lenka Cerna; Peter Wohlfahrt; Renata Cifkova; Elke Theuwissen; Cees Vermeer

doi:10.1016/j.atherosclerosis.2014.04.027

Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease

Otto, Jr. Mayer^*, Jitka Seidlerova, Jan Bruthans, Jan Filipovsky, Katarina Timoracka, Jiri Vanek, Lenka Cerna, Peter Wohlfahrt, Renata Cifkova, Elke Theuwissen, Cees Vermeer

^*Corresponding author for this work

Biochemie

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	162-168
Journal	Atherosclerosis
Volume	235
Issue number	1
DOIs	https://doi.org/10.1016/j.atherosclerosis.2014.04.027
Publication status	Published - Jul 2014

Keywords

Matrix Gla-protein
Dp-ucMGP
Dp-cMGP
Mortality
Coronary heart disease
Stroke
Secondary prevention
EUROASPIRE

Access to Document

10.1016/j.atherosclerosis.2014.04.027

Cite this

Mayer, O. J., Seidlerova, J., Bruthans, J., Filipovsky, J., Timoracka, K., Vanek, J., Cerna, L., Wohlfahrt, P., Cifkova, R., Theuwissen, E., & Vermeer, C. (2014). Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. Atherosclerosis, 235(1), 162-168. https://doi.org/10.1016/j.atherosclerosis.2014.04.027

Mayer, Otto, Jr. ; Seidlerova, Jitka ; Bruthans, Jan ; Filipovsky, Jan ; Timoracka, Katarina ; Vanek, Jiri ; Cerna, Lenka ; Wohlfahrt, Peter ; Cifkova, Renata ; Theuwissen, Elke ; Vermeer, Cees. / Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. In: Atherosclerosis. 2014 ; Vol. 235, No. 1. pp. 162-168.

@article{972a43f619f34b7e873a4f2673842029,

title = "Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease",

keywords = "Matrix Gla-protein, Dp-ucMGP, Dp-cMGP, Mortality, Coronary heart disease, Stroke, Secondary prevention, EUROASPIRE",

author = "Mayer, {Otto, Jr.} and Jitka Seidlerova and Jan Bruthans and Jan Filipovsky and Katarina Timoracka and Jiri Vanek and Lenka Cerna and Peter Wohlfahrt and Renata Cifkova and Elke Theuwissen and Cees Vermeer",

year = "2014",

month = jul,

doi = "10.1016/j.atherosclerosis.2014.04.027",

language = "English",

volume = "235",

pages = "162--168",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

Mayer, OJ, Seidlerova, J, Bruthans, J, Filipovsky, J, Timoracka, K, Vanek, J, Cerna, L, Wohlfahrt, P, Cifkova, R, Theuwissen, E & Vermeer, C 2014, 'Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease', Atherosclerosis, vol. 235, no. 1, pp. 162-168. https://doi.org/10.1016/j.atherosclerosis.2014.04.027

Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. / Mayer, Otto, Jr.; Seidlerova, Jitka; Bruthans, Jan; Filipovsky, Jan; Timoracka, Katarina; Vanek, Jiri; Cerna, Lenka; Wohlfahrt, Peter; Cifkova, Renata; Theuwissen, Elke; Vermeer, Cees.

In: Atherosclerosis, Vol. 235, No. 1, 07.2014, p. 162-168.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease

AU - Mayer, Otto, Jr.

AU - Seidlerova, Jitka

AU - Bruthans, Jan

AU - Filipovsky, Jan

AU - Timoracka, Katarina

AU - Vanek, Jiri

AU - Cerna, Lenka

AU - Wohlfahrt, Peter

AU - Cifkova, Renata

AU - Theuwissen, Elke

AU - Vermeer, Cees

PY - 2014/7

Y1 - 2014/7

KW - Matrix Gla-protein

KW - Dp-ucMGP

KW - Dp-cMGP

KW - Mortality

KW - Coronary heart disease

KW - Stroke

KW - Secondary prevention

KW - EUROASPIRE

U2 - 10.1016/j.atherosclerosis.2014.04.027

DO - 10.1016/j.atherosclerosis.2014.04.027

M3 - Article

C2 - 24835435

VL - 235

SP - 162

EP - 168

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -